Jun 14, 2021 | Brand Name Drugs, Comparative Effectiveness, MedBen Rx, Prescription drugs, Rx Costs, Savings, Specialty Drugs
The prices of 260 popular brand-name prescription drugs rose 3% from 2019 to 2020 – twice as much as the 1.3% rate of inflation during the same period, according to a new AARP report. Their analysis also found that over the past 15 years, prices of 65 common brands...
Jan 10, 2021 | Brand Name Drugs, MedBen Rx, Rx Costs, Rx prices, Specialty Drugs
GoodRx has compiled a list of drugs that saw manufacturer price increases in January 2021. In total, 589 drugs – all but seven of them brand-name medications – increased in price, by an average of 4.2%. Among the better known brand-name drugs on the list are Humira...
Oct 20, 2020 | Brian Fargus, Caroline Fraker, MedBen employees, MedBen Rx, Pharmacogenomics, Specialty Drugs
MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
Sep 5, 2020 | Prescription drugs, Specialty Drugs
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
Feb 28, 2019 | Government, Legislation, MedBen Rx, Rx Costs, Rx Spending, Specialty Drugs
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Dec 2, 2018 | Brand Name Drugs, Generic Drugs, MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Specialty Drugs
Modern Healthcare recently highlighted the growing disparity between brand-names and generics in relation to prescription drug spending. A new study finds that while total spending on generic drugs has declined, branded prescription drug spending continues to rise. In...
